SPIRIT – Assessing clinical parameters associated with using IDegLira in patients with Type 2 Diabetes in a real-world setting in Colombia: a single arm, retrospective, chart review study
Abstract:Aim.
Insulin degludec/liragultide (IDegLira) is a fixed-ratio co-formulation of insulin degludec (a basal insulin) and liraglutide (GLP-1RA). This study aimed to investigate clinical outcomes in people with type 2 diabetes (T2D) after initiating IDegLira treatment in a real-world setting in Colombia.
Methods.
SPIRIT is a non-interventional, single-arm, retrospective chart review study to assess clinical outcomes in people with Type 2 Diabetes (T2D). These patients were switched from basal insulin (with or with… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.